Case Western Study Warns Popular Vitamin B3 Supplements May Shield Pancreatic Cancer Cells from Chemotherapy Effects

A Case Western study finds NAD+ supplements like NMN can help pancreatic cancer cells survive chemo, shielding tumors from DNA damage and oxidative stress.

By: AXL Media

Published: Apr 2, 2026, 4:34 AM EDT

Source: Information for this report was sourced from Case Western Reserve University.

The Biological Double-Edged Sword of NAD+ Supplementation

Millions of individuals utilize vitamin B3 derivatives such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) under the assumption that boosting NAD+ levels will enhance cellular energy and slow the aging process. However, new research published in the journal Cancer Letters suggests that these same metabolic fuels may create a protective environment for one of the world's most aggressive malignancies. Every cell in the human body requires NAD+ to function, but the study reveals that pancreatic cancer cells are particularly adept at hijacking these supplemental precursors. By flooding the system with additional fuel, patients may be inadvertently providing cancer cells with the resources necessary to withstand aggressive clinical interventions.

Neutralizing the Lethal Mechanisms of Chemotherapy

The primary objective of chemotherapy is to induce cellular death by creating oxidative stress and irreparable DNA damage within a tumor. The Case Western Reserve School of Medicine team found that NAD+ supplements specifically undermine this process in three distinct ways. First, the supplements provide a surge of energy that makes tumors more resilient against external stress. Second, they neutralize oxidative stress, effectively disarming the chemical "weapons" that drugs like oxaliplatin and gemcitabine use to destroy malignant cells. Finally, the increased NAD+ levels allow cancer cells to rapidly repair their own genetic material, blocking the very pathway to cell death that oncologists rely on to shrink tumors.

Experimental Evidence in Laboratory and Animal Models

To validate their hypotheses, the researchers conducted a series of experiments using both cultured human pancreatic cancer cells and mouse models. The results consistently showed that NMN, in particular, acted as a biological shield for the cancer cells when exposed to standard chemotherapy regimens. In the presence of these B3 derivatives, tumors were able to survive doses of medication that would otherwise be lethal. This shielding effect was observed across three of the most common chemotherapy drugs currently used to treat pancreatic cancer: oxaliplatin, 5-fluorouracil, and gemcitabine. These findings suggest that the metabolic advantages provided by the supplements are significant enough to alter the clinical outcom...